Anti-DRAK2 antibody
-
概述
- 产品描述catalytic activity:ATP + a protein = ADP + a phosphoprotein. Acts as a positive regulator of apoptosis. PTM:Autophosphorylated. Belongs to the protein kinase superfamily. Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family. DAP kinase subfamily. Contains 1 protein kinase domain. subunit:Interacts with CHP causing CHP to translocate from the Golgi to the nucleus. tissue specificity:Highly expressed in placenta, lung, pancreas. Lower levels in heart, brain, liver, skeletal muscle and kidney.
- 产品名称Anti-DRAK2 antibody
- 分子量45 kDa
- 种属反应性Human, Mouse, Rat
- 验证应用WB, IHC-P
- 抗体类型兔多抗
- 免疫原The antiserum was produced against synthesized peptide derived from human STK17B. AA range:251-300
- 偶联Non-conjugated
-
性能
- 形态Liquid
- 浓度1 mg/mL.
- 存放说明Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles.
- 存储缓冲液Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
- 亚型IgG
- 纯化方式Immunogen affinity purified.
- 其它名称STK17B antibody; DRAK2 antibody; Serine/threonine-protein kinase 17B antibody; DAP kinase-related apoptosis-inducing protein kinase 2 antibody;
-
应用
WB: 1:500-1:2000
IHC-P: 1:100-1:300
-
Fig1: Western Blot analysis of various cells using DRAK2 Polyclonal Antibody cells nucleus extracted by Minute TM Cytoplasmic and Nuclear Fractionation kit (SC-003,Inventbiotech,MN,USA).
特别提示：本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！
